A carregar...

Antibody-drug conjugates: Intellectual property considerations

Antibody-drug conjugates are highly complex entities that combine an antibody, a linker and a toxin. This complexity makes them demanding both technically and from a regulatory point of view, and difficult to deal with in their patent aspects. This article discusses different issues of patent protec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Autor principal: Storz, Ulrich
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966491/
https://ncbi.nlm.nih.gov/pubmed/26292154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1082019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!